MedTrace Logo

Anesthesia for Vascular Access Devices

NCT04749069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2021-02-10

No results posted yet for this study

Summary

Our aim was to investigate whether remifentanil use in both infusion and bolus techniques could provide sufficient sedation and analgesia without serious adverse effects for central venous access device procedures under monitored anesthesia care.

Conditions

  • Opioid Use, Unspecified
  • Remifentanil
  • Sedation Complication
  • Analgesia
  • Satisfaction, Patient
  • Vascular Access Complication

Interventions

DIAGNOSTIC_TEST

Comparison of pain intensity rating scale

Comparison of numerical pain intensity rating scale Comparison of faces pain rating scale Comparison of consumption of total amount of remifentanil

Sponsors & Collaborators

  • Trakya University Faculty of Medicine

    collaborator UNKNOWN

  • Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-01
Primary Completion
2020-04-30
Completion
2020-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749069 on ClinicalTrials.gov